The EPS beat and raised guidance floor are positive, but the 1.9% revenue growth and narrowed EBITDA guidance suggest limited acceleration. Monitor the Q3 sequential revenue growth commentary for signs of re-acceleration, as the company guided for low-to-mid single-digit sequential revenue growth.
Price Chart
Executive Summary
Option Care Health reported Q2 2026 adjusted diluted EPS of $0.45, a 9.8% YoY increase and a 5.4% beat vs. the $0.43 consensus. Revenue of $1.442B grew 1.9% YoY, slightly above the $1.42B estimate. The company maintained its full-year 2026 revenue guidance of $5.675B-$5.775B but narrowed its adjusted EBITDA guidance to $480M-$495M from $480M-$505M, and raised the low end of its adjusted EPS guidance to $1.85-$1.92 from $1.82-$1.92. The beat was driven by operational execution and a $150M share repurchase, but the modest top-line growth and narrowed EBITDA range temper the bullish read-through.
Key Financial Metrics
Key Facts
- Adjusted diluted EPS of $0.45 beat consensus of $0.43 by 5.4%
- Revenue of $1.442B grew 1.9% YoY, slightly above $1.42B estimate
- GAAP net income of $53.9M was up 6.7% YoY
- Adjusted EBITDA of $117.5M was up 3.0% YoY
- Cash provided by Q2 operating activities was $184M
- Repurchased $150M of outstanding shares in the quarter
- Full-year 2026 revenue guidance maintained at $5.675B-$5.775B
- Full-year 2026 adjusted EPS guidance raised to $1.85-$1.92 from $1.82-$1.92
- Full-year 2026 adjusted EBITDA guidance narrowed to $480M-$495M from $480M-$505M
Financial Impact
EPS beat of $0.02 (5.4%) on $1.442B revenue; $150M share repurchase in quarter
Risk Factors
- Revenue growth remains modest at 1.9% YoY, below historical trends
- Narrowed adjusted EBITDA guidance range suggests limited margin expansion in H2
- Significant share repurchase ($150M) reduces share count but also cash reserves
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001014739-26-000021 |
| Document: bios-20260729.htm | 0001014739-26-000021 |
| Document: 0001014739-26-000021-index-headers.html | 0001014739-26-000021 |
| Document: 0001014739-26-000021-index.html | 0001014739-26-000021 |
| Document: 0001014739-26-000021.txt | 0001014739-26-000021 |
| 8-K Data (Synthetic) | 0001014739-26-000021 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | SC 13G/A | $31.28 | awaiting T+5 | — | $31.23 (−0.16%) |
Oct 6, 2026 21d ago | DEFA14A | $31.01 $31.12 | ▲ +0.35% | ▲ +1.34% | $31.23 (+0.71%) |
Oct 6, 2026 21d ago | DEFA14A | $31.00 $31.10 | ▲ +0.32% | ▲ +0.46% | $31.23 (+0.74%) |
Oct 6, 2026 21d ago | 8-K | $31.00 $31.10 | ▲ +0.32% | ▲ +0.46% | $31.23 (+0.74%) |
Jul 29, 2026 12w ago | 8-K | $23.93 $23.70 | ▼ −0.96% | ▼ −6.49% | $31.23 (+30.51%) |
Jun 4, 2026 20w ago | Press Release | $20.07 $20.78 | ▲ +3.54% | ▲ +6.09% | $31.23 (+55.61%) |
May 12, 2026 24w ago | 8-K | $19.59 $19.69 | ▲ +0.51% | ▲ +0.43% | $31.23 (+59.42%) |
May 4, 2026 25w ago | Insider Cluster | $21.30 $19.59 | ▼ −8.03% | ▼ −10.02% | $31.23 (+46.62%) |
May 4, 2026 25w ago | Insider Cluster | $21.30 $19.59 | ▼ −8.03% | ▼ −10.02% | $31.23 (+46.62%) |
May 4, 2026 25w ago | Insider Cluster | $21.30 $19.59 | ▼ −8.03% | ▼ −10.02% | $31.23 (+46.62%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers